LDS/Medical Tests/Spinobulbar Muscular Atrophy (Kennedy Disease), Androgen Receptor Gene Mutation Analysis

Spinobulbar Muscular Atrophy (Kennedy Disease), Androgen Receptor Gene Mutation Analysis

Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy disease, is a gradually progressive neuromuscular disorder. Affected males will typically present between the age of 30 to 50 years of age with muscle weakness affecting the facial, bulbar and limb muscles, muscular atrophy, and fasciculations. SBMA mainly affects males and females are generally asymptomatic carriers. Other clinical features may include gynecomastia, testicular atrophy, and reduced fertility as a result of androgen insensitivity. When the disease progresses, involvement of the bulbar muscles may lead to dysphagia and difficulty with speech articulation.

SBMA is X-linked inherited disease affecting fewer than 1 in 150,000 males and is caused an abnormal expansion of cytosine-adenine-guanine (CAG) triplet repeats in the androgen receptor (AR) gene at Xq11-12. Normally, the number of CAG trinucleotide repeats in the AR gene range from 5 to 34. In full penetrance pathogenic alleles, the number is increased to > 38 repeats. The extended CAG region changes the structure of the androgen receptor and the altered protein may be toxic to neurons. The age of onset correlates with length of the CAG repeat, with onset occurring earlier in patients with longer repeats. The diagnosis of SBMA is established in a male proband by the identification of a hemizygous expansion of a CAG trinucleotide repeats (>35 CAGs) in AR by molecular genetic testing.

  • Diagnostic confirmation of familial spinobulbar muscular atrophy (SBMA)
  • Carrier screening in families at risk
  • For the prenatal diagnosis of known familial mutation(s) in at-risk pregnancies
  • Normal alleles - 34 or fewer CAG trinucleotide repeats
  • Reduced penetrance - 36-37 CAG trinucleotide repeats
  • Pathogenic allele - > 38 CAG trinucleotide repeats

Normal alleles: 11-34 CAG repeats

Fragment length analysis of the CAG repeat region within AR by polymerase chain reaction (PCR), conventional sequencing, next generation sequencing (NGS). 

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
Creatine kinase levels, fertility testing, muscle biopsy.
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Eur J Neurol. 2009;16: 556-61. [PMID: 19405197]
  • J Neurophysiol. 2009;101: 1171-8. [PMID: 19118107]
  • Horm Behav. 2008;53: 729-40. [PMID: 18321505]
  • Neurology. 2002;59: 770-2. [PMID: 12221177]
  • J Neurol Sci. 1996;135: 149-57. [PMID: 8867071]
  • GeneReviews® [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK1333/
  • Genetics Home Reference. Available: https://ghr.nlm.nih.gov/condition/spinal-and-bulbar-muscular-atrophy#